Analyst Ratings for King Pharmaceuticals (KG)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2014 | RBC Capital | N/A | Downgrade | Sector Perform (Outperform) |
15.00 (24.00) |
14.24 (14.24) |
0% | Details |
| 10/13/2010 | Wells Fargo | N/A | Downgrade | Equal Weight (N/A) |
N/A (N/A) |
14.14 (14.24) |
0.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
